3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
43
Leukemia, Myeloid, Acute
25
Recurrence
21
Lymphoma, Large B-Cell, Diffuse
12
Sarcoma
8
Neoplasms, Plasma Cell
5
Neoplasm Metastasis
5
Lymphoma
5
Glioblastoma
5
Ovarian Neoplasms
4
Neurofibrosarcoma
4
Neoplasms
4
Melanoma
4
Lymphoma, Non-Hodgkin
4
Endometrial Neoplasms
4
Colorectal Neoplasms
4
Triple Negative Breast Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Myelodysplastic Syndromes
3
Lymphoma, T-Cell, Peripheral
3
Lymphoma, Extranodal NK-T-Cell
3
Lymphoma, B-Cell
3
Liposarcoma
3
Glioma
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma
3
Waldenstrom Macroglobulinemia
2
Thymoma
2
Sarcoma, Alveolar Soft Part
2
Rhabdoid Tumor
2
Interventions
Dexamethasone
49
Melphalan
29
Cyclophosphamide
24
Bortezomib
23
Filgrastim
18
Calcium Dobesilate
18
Peripheral Blood Stem Cell Transplantation
16
daratumumab
13
pomalidomide
10
dexamethasone acetate
8
Lenalidomide
8
ixazomib
6
fludarabine phosphate
6
dexamethasone 21-phosphate
6
venetoclax
5
birtamimab
5
auricularum
5
Whole-Body Irradiation
5
Thalidomide
5
Mycophenolic Acid
5
Granulocyte Colony-Stimulating Factor
5
Cyclosporine
5
Radiotherapy
4
Interferon-alpha
4
Etoposide
4
Carboplatin
4
Busulfan
4
sargramostim
3
miridesap
3
isatuximab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Immunoglobulin Light-chain Amyloidosis
×
selinexor
×
Clear all
NCT04984330
2022-11-17
STARR
Weill Medical College of Cornell University
Phase EARLY_PHASE1
Withdrawn